Non-Controlling Interest (NCI) - Recognition at Acquisition Date (Full Goodwill Method)
Recording the non-controlling interest at its fair value on the acquisition date — the 'full goodwill' method used in ASC 805 (US GAAP mandatory) and available as an option under IFRS 3.
| Account Name | Type | Debit ($) | Credit ($) |
|---|---|---|---|
| Net Assets of Subsidiary (FV of 100% Consolidated) | Asset (+) Net | 148,000,000.00 | - |
| Goodwill (Full Goodwill — includes NCI's share) | Asset (+) | 62,000,000.00 | - |
| Investment in Subsidiary (80% Consideration Paid) | Asset (-) | - | 168,000,000.00 |
| Non-Controlling Interest — NCI (20% at Fair Value) | Equity (+) | - | 42,000,000.00 |
💡 Accountant's Note
When a parent acquires 80% of a subsidiary, the remaining 20% is held by non-controlling interest (NCI) shareholders — outside the parent's control but still consolidated because the parent has control. Under ASC 805 / IFRS 3 full goodwill method: NCI is measured at its FAIR VALUE on the acquisition date (not just 20% of the subsidiary's net book value). Full goodwill includes both the parent's and NCI's share: Parent's goodwill = 80% share of FV premium over net assets. NCI's goodwill = 20% × (FV of the 100% business − FV of net identifiable assets). The NCI balance on the consolidated balance sheet represents the equity of the minority shareholders in the consolidated subsidiary — it is classified as equity (NOT mezzanine, NOT liability) for standard NCI.
Practitioner & Systems Framework
💻 ERP Architecture
NCI is presented as a separate component of consolidated equity — distinct from the parent's equity. The consolidated income statement shows net income attributable to parent shareholders and separately, net income attributable to NCI. The consolidated statement of equity shows NCI as a separate column. Each subsidiary with NCI requires its own NCI rollforward: Beginning NCI + NCI share of income − NCI dividends +/− NCI share of OCI + NCI changes from equity transactions = Ending NCI.
⚠️ Audit Flags
NCI valuation at acquisition date is a key audit area — particularly for private subsidiary NCIs where there is no observable market price. The fair value of the 20% NCI is NOT simply 20% × (80% consideration / 80%) = $210M × 20% = $42M (though this approximation is sometimes used). A proper FV of NCI accounts for any control premium embedded in the parent's 80% purchase price — the NCI might be valued at a discount to the implied 100% value.
📄 Required Documentation
NCI fair value calculation (independent valuation or reasoned approximation), identification of NCI shareholders, NCI rollforward workpaper, consolidated equity presentation showing NCI as separate column.
Professional Excel Template
Get the automated version of this entry. Includes built-in IFRS checks, VAT calculators, and SAP-ready upload formats.
Expert Analysis by Qusai Ahmad
General Accountant Supervisor & IFRS Specialist
Specialized in SAP GUI automation and Middle Eastern tax compliance. Building digital tools for the next generation of finance leaders.
Related Journal Entries
Holding Companies & Consolidations
Business Combination - Purchase Price Allocation (ASC 805) at Acquisition Date
Holding Companies & Consolidations
Goodwill - Initial Recognition and Components (Excess Purchase Price over Net Identifiable Assets)
Holding Companies & Consolidations